A comprehensive view of GSK Group (GlaxoSmithKline). This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

GSK releases statement regarding Zantac ranitidine litigation

US District Court finds nearly 50,000 lawsuits against GSK, Pfizer, Sanofi, Boehringer Ingelheim alleging heartburn drug Zantac causes cancer not backed by sound science; tens of thousands of similar cases are pending in state courts across US

Patent Issued for Methods for determining resistance or susceptibility to HIV entry inhibitors (USPTO 11499200)

GSK recalls certain Tums antacid tablets in Canada due to possible fiberglass, paper, aluminum foil contamination; recall involves Tums tablets sold in package of three rolls contain 12 tablets each distributed in Canada starting October 25

European Medicines Agency accepts GSK's marketing authorization application for momelotinib for the treatment of myelofibrosis, a type of bone marrow cancer; myelofibrosis affects approximately 20,000 patients in the US

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count